arrow
A

Adel Shahnam

Memorial Sloan Kettering Cancer Center
H指数:9
被引数:256

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience

侵袭性血管肌纤维母细胞瘤的自然病史和治疗结果:单一机构经验

2026-09-010
PRE
Perspectives of People Affected by Cancer Toward Generative AI in Oncology: A Scoping Review of Applications, Evidence Gaps, and Future Priorities

癌症患者对肿瘤学中生成式人工智能的展望:一项关于应用、证据空白和未来重点的范围综述

2026-08-140
PRE
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

肉瘤中合并用药对免疫治疗结局的影响:七项II期试验的汇总事后分析

2026-06-210
OAAI
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory

基于RNA的基因融合检测在肉瘤诊断和管理中的临床应用价值:澳大利亚实验室的经验

2025-11-110
PRE
Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer

澳大利亚老年不可切除的III期非小细胞肺癌患者放化疗后巩固durvalumab的真实世界疗效和毒性

2024-03-015
OA